Medicine combination for treating human neuroglioma during nursing

Abstract

The invention relates to a medicine combination for treating human neuroglioma during nursing. The medicine combination comprises an effective quantity of compound and a pharmaceutically acceptable carrier, and the compound is of a structure in the specification. The compound of the medicine combination has growth inhibition activity on human neuroglioma cells.

Description

technical field [0001] The invention relates to the field of medicine, in particular to a pharmaceutical composition for treating human glioma in nursing. Background technique [0002] Glioma, also known as glioma, is a variety of tumors that occur in the neuroectoderm, and is the most common in various intracranial tumors. Due to the anatomical characteristics of the nervous system and the head, gliomas are rare Metastasis to other tissues through the vasculature, mostly intracranial. [0003] At present, the treatment methods for glioma cells include surgery, radiotherapy, etc., but the overall curative effect is still unsatisfactory. After surgical resection of tumor tissue, some highly metastatic glioma cells can even transfer to distant sites through the vasculature. However, these metastatic glioma cells are often not sensitive to radiotherapy, chemotherapy, etc., so it is difficult to be eradicated, and hidden dangers are always present. Therefore, it is necessary t...

AI Technical Summary

Problems solved by technology

[0003] At present, the treatment methods for glioma cells include surgery, radiotherapy, etc., but the overall curative effect is still unsatisfactory. After surgical resection of tumor tissue, some highly metastatic glioma cells can even transfer to distant sites through the vasculature. in other organs, but these metastatic glioma cells are often insensitive to radiotherapy, chemotherapy, etc., so it is difficult to be eradicated.

Images